Home > National Drug Code (NDC) > LISINOPRIL AND HYDROCHLOROTHIAZIDE

LISINOPRIL AND HYDROCHLOROTHIAZIDE - 68180-520-02 - (LISINOPRIL AND HYDROCHLOROTHIAZIDE)

Alphabetical Index


Drug Information of LISINOPRIL AND HYDROCHLOROTHIAZIDE

Product NDC: 68180-520
Proprietary Name: LISINOPRIL AND HYDROCHLOROTHIAZIDE
Non Proprietary Name: LISINOPRIL AND HYDROCHLOROTHIAZIDE
Active Ingredient(s): 25; 20    mg/1; mg/1 & nbsp;   LISINOPRIL AND HYDROCHLOROTHIAZIDE
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of LISINOPRIL AND HYDROCHLOROTHIAZIDE

Product NDC: 68180-520
Labeler Name: Lupin Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA077912
Marketing Category: ANDA
Start Marketing Date: 20061004

Package Information of LISINOPRIL AND HYDROCHLOROTHIAZIDE

Package NDC: 68180-520-02
Package Description: 500 TABLET in 1 BOTTLE (68180-520-02)

NDC Information of LISINOPRIL AND HYDROCHLOROTHIAZIDE

NDC Code 68180-520-02
Proprietary Name LISINOPRIL AND HYDROCHLOROTHIAZIDE
Package Description 500 TABLET in 1 BOTTLE (68180-520-02)
Product NDC 68180-520
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name LISINOPRIL AND HYDROCHLOROTHIAZIDE
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20061004
Marketing Category Name ANDA
Labeler Name Lupin Pharmaceuticals, Inc.
Substance Name HYDROCHLOROTHIAZIDE; LISINOPRIL
Strength Number 25; 20
Strength Unit mg/1; mg/1
Pharmaceutical Classes Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]

Complete Information of LISINOPRIL AND HYDROCHLOROTHIAZIDE


General Information